Vivek Naranbhai

Vivek Naranbhai

Auto-generated profile, based on publicly available information

Vivek Naranbhai

Monash University 7 Department of Cancer Medicine Melbourne, Australia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2014 in Science
Verified
Journal Article
Open access
PDF file
BFBenjamin P. Fairfax
Benjamin P. Fairfax
PHPeter Humburg
Peter Humburg
SMSeiko Makino
Seiko Makino
VNVivek Naranbhai
Vivek Naranbhai
DWDaniel Wong
Daniel Wong
JKJulian C. Knight
Julian C. Knight
Immune Variation: It is difficult to determine the mechanistic consequences of context-dependent genetic variants, some of which may be related to disease (see the Perspective by Gregersen ). Two studies now report on the effects of stimulating immunological monocytes and dendritic cells with proteins that can elicit a response to bacterial or viral infection and assess the functional links between genetic variants and profiles of gene expression. M. N. Lee et al. ( 10.1126/science.1246980 ) analyzed the expression of more than 400 genes, in dendritic cells from 30 healthy subjects, which revealed how expression quantitative trait loci (eQTLs) affect gene expression within the interferon-β and the Toll-like receptor 3 and 4 pathways. Fairfax et al. ( 10.1126/science.1246949 ) performed a genome-wide analysis to show that many eQTLs affected monocyte gene expression in a stimulus- or time-specific manner.

21 April 2015 in Clinical Infectious Diseases
Verified
Journal Article
Closed access
PDF file
LMLindi Masson
Lindi Masson
JPJo-Ann S. Passmore
Jo-Ann S. Passmore
LLLenine J. Liebenberg
Lenine J. Liebenberg
LWLise Werner
Lise Werner
CBCheryl Baxter
Cheryl Baxter
SKSalim S. Abdool Karim
Salim S. Abdool Karim
Background. Women in Africa, especially young women, have very high human immunodeficiency virus (HIV) incidence rates that cannot be fully explained by behavioral risks. We investigated whether genital inflammation influenced HIV acquisition in this group. Methods. Twelve selected cytokines, including 9 inflammatory cytokines and chemokines (interleukin [IL]-1α, IL-1β, IL-6, tumor necrosis factor-α, IL-8, interferon-γ inducible protein-10 [IP-10], monocyte chemoattractant protein-1, macrophage inflammatory protein [MIP]-1α, MIP-1β), hematopoietic IL-7, and granulocyte macrophage colony-stimulating factor, and regulatory IL-10 were measured prior to HIV infection in cervicovaginal lavages from 58 HIV seroconverters and 58 matched uninfected controls and in plasma from a subset of 107 of these women from the Centre for the AIDS Programme of Research in South Africa 004 tenofovir gel trial. Results. HIV seroconversion was associated with raised genital inflammatory cytokines (including chemokines MIP-1α, MIP-1β, and IP-10). The risk of HIV acquisition was significantly higher in women with evidence of genital inflammation, defined by at least 5 of 9 inflammatory cytokines being raised (odds ratio, 3.2; 95% confidence interval, 1.3–7.9; P = .014). Genital cytokine concentrations were persistently raised (for about 1 year before infection), with no readily identifiable cause despite extensive investigation of several potential factors, including sexually transmitted infections and systemic cytokines. Conclusions. Elevated genital concentrations of HIV target cell–recruiting chemokines and a genital inflammatory profile contributes to the high risk of HIV acquisition in these African women.

3 February 2022 in Cell
Verified
Journal Article
Open access
VNVivek Naranbhai
Vivek Naranbhai
ANAnusha Nathan
Anusha Nathan
CKClarety Kaseke
Clarety Kaseke
CBCristhian Berrios
Cristhian Berrios
AKAshok Khatri
Ashok Khatri
GGGaurav D. Gaiha
Gaurav D. Gaiha
The SARS-CoV-2 Omicron variant (B.1.1.529) contains mutations that mediate escape from antibody responses, although the extent to which these substitutions in spike and non-spike proteins affect T cell recognition is unknown. In this study, we show that T cell responses in individuals with prior infection, vaccination, both prior infection and vaccination, and boosted vaccination are largely preserved to Omicron spike and non-spike proteins. However, we also identify a subset of individuals (∼21%) with a >50% reduction in T cell reactivity to the Omicron spike. Evaluation of functional CD4+ and CD8+ memory T cell responses confirmed these findings and revealed that reduced recognition to Omicron spike is primarily observed within the CD8+ T cell compartment potentially due to escape from HLA binding. Booster vaccination enhanced T cell responses to Omicron spike. In contrast to neutralizing immunity, these findings suggest preservation of T cell responses to the Omicron variant, although with reduced reactivity in some individuals.

24 July 2012 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
VNVivek Naranbhai
Vivek Naranbhai
SKSalim S. Abdool Karim
Salim S. Abdool Karim
MAMarcus Altfeld
Marcus Altfeld
NSNatasha Samsunder
Natasha Samsunder
RDRaveshni Durgiah
Raveshni Durgiah
WCWilliam H. Carr
William H. Carr
The antiretroviral agent, tenofovir, formulated as a vaginal microbicide gel, reduces human immunodeficiency virus (HIV) acquisition by 39% in women. This study assessed the role of preexisting immune activation in HIV acquisition in women from the CAPRISA 004 trial, to identify potential strategies to increase the effectiveness of tenofovir gel. Systemic cytokine and cellular immune mediators (platelets and natural killer [NK] cells) were assessed in women at high risk for HIV assigned to either tenofovir or placebo gel in the CAPRISA 004 trial. Notwithstanding tenofovir gel use, women who acquired HIV had significantly higher systemic innate immune activation prior to infection than women who remained uninfected. Activation of both soluble (cytokine) and cellular (NK cells) immune mediators were associated with HIV acquisition, individually or in combination. Hence, an innate immune activation suppressant could be added to tenofovir gel as a potential combination gel strategy in developing the next generation of higher efficacy antiretroviral microbicides.

5 January 2018 in Science
Verified
Journal Article
Open access
PDF file
VRVeron Ramsuran
Veron Ramsuran
VNVivek Naranbhai
Vivek Naranbhai
AHAmir Horowitz
Amir Horowitz
YQYing Qi
Ying Qi
MMMaureen P. Martin
Maureen P. Martin
MCMary Carrington
Mary Carrington
Inhibiting natural killer cells in AIDS: The human leukocyte antigen (HLA) gene complex varies enormously among individuals and helps explain individual variation in immunity to infectious diseases. Ramsuran et al. examined data from almost 10,000 HIV infections. Expression of the HLA-A and - B alleles was associated with higher viral load, reduced CD4 + T cell counts, and accelerated progression to AIDS. Higher levels of HLA-A expression increased expression of HLA-E , which blocks a specific receptor (NKG2A) on the immune cells that normally eliminate virus-infected cells. Thus, targeting NKG2A might provide a therapeutic avenue for HIV treatment. Science , this issue p. 86

7 July 2015 in Nature Communications
Verified
Journal Article
Open access
PDF file
VNVivek Naranbhai
Vivek Naranbhai
BFBenjamin P. Fairfax
Benjamin P. Fairfax
SMSeiko Makino
Seiko Makino
PHPeter Humburg
Peter Humburg
DWDaniel Wong
Daniel Wong
JKJulian C. Knight
Julian C. Knight
Neutrophils form the most abundant leukocyte subset and are central to many disease processes. Technical challenges in transcriptomic profiling have prohibited genomic approaches to date. Here we map expression quantitative trait loci (eQTL) in peripheral blood CD16+ neutrophils from 101 healthy European adults. We identifycis-eQTL for 3281 neutrophil-expressed genes including many implicated in neutrophil function, with 450 of these not previously observed in myeloid or lymphoid cells. Paired comparison with monocyte eQTL demonstrates nuanced conditioning of genetic regulation of gene expression by cellular context, which relates to cell-type-specific DNA methylation and histone modifications. Neutrophil eQTL are markedly enriched for trait-associated variants particularly autoimmune, allergy and infectious disease. We further demonstrate how eQTL inPADI4andNOD2delineate risk variant function in rheumatoid arthritis, leprosy and Crohn’s disease. Taken together, these data help advance understanding of the genetics of gene expression, neutrophil biology and immune-related diseases.